Do you want to read an article? Please log in or register.
Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - An observational study
Lipid-Lowering Drugs
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Treatment pathways of lipid-lowering therapies in Germany 2016-2022
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Clin Res Cardiol
Katzmann JL, Grellmann C, Leppert B, Müller-Kozarez I, Schulz M, Laufs U
doi: 10.1007/s00392-025-02686-5
RECOMMENDED
Cardiovascular Risk and Diseases
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862
Heart, Artery and Coronary DiseasesTherapy and Intervention
Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT
Am Heart J
Thuraiaiyah J, Jørgensen TH, Jensen JM, Fuchs A, Willemen Y, Terkelsen CJ, Kofoed KF, Søndergaard L, Nørgaard B, De Backer O
doi: 10.1016/j.ahj.2024.10.002
Heart Failure
Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
Circulation
Basile C, Lindberg F, Benson L, Guidetti F, Dahlström U, Piepoli MF, Mol P, Scorza R, Maggioni AP, Lund LH, Savarese G
doi: 10.1161/CIRCULATIONAHA.124.072855
RECOMMENDED
Heart, Artery and Coronary Diseases
Long-Term Lipid Lowering With Evolocumab in Older Individuals
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Coll Cardiol
Al Said S, O'Donoghue ML, Ran X, Murphy SA, Atar D, Keech A, Flores-Arredondo JH, Wang B, Sabatine MS, Giugliano RP
doi: 10.1016/j.jacc.2024.11.019
Heart, Artery and Coronary Diseases
Myocarditis in Patients Starting Combination Checkpoint Inhibitor Therapy: Analysis of a Commercial Claims Database
J Am Heart Assoc
Lindsay AC, Walker AM, Schneeweiss S
doi: 10.1161/JAHA.124.035689
RECOMMENDED
Myocardial Infarction
Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Biccirè FG, Kakizaki R, Koskinas KC, Ueki Y, Häner J, Shibutani H, Lønborg J, Spitzer E, Iglesias JF, Otsuka T, Siontis GCM, Stortecky S, Kaiser C, Ambühl M, Morf L, Ondracek AS, van Geuns RJ, Spirk D, Daemen J, Mach F, Windecker S, Engstrøm T, Lang I, Losdat S, Räber L
doi: 10.1001/jamacardio.2024.3200
Heart, Artery and Coronary Diseases
Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy
Heart Rhythm
Iwawaki T, Inden Y, Yanagisawa S, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T
doi: 10.1016/j.hrthm.2025.02.002
SPECIAL REPORT
Atrial Fibrillation